Psoriatic arthritis trials in Türkiye
5 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
- Where
- Istanbul
- Age
- 1 year to 18 years
- People
- 190 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT03773965 - Phase 3Taking peopleA Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis
- Where
- Ankara, Istanbul
- Age
- 5 years to 18 years
- People
- 48 worldwide
- Run by
- Amgen
See details and how to joinNCT05767047 - Phase 3Taking peopleA Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Where
- Ankara, Istanbul, Kocaeli
- Age
- 3 years to 64 years
- People
- 196 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00 - Phase 3Taking peopleApremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis
- Where
- Ankara, Istanbul
- Age
- 5 years to 17 years
- People
- 60 worldwide
- Run by
- Amgen
See details and how to joinNCT04804553 · EU 2023-503435-17-00 - Phase 3Taking peopleA Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis
- Where
- Ankara, Istanbul, İstanbul - Fatih
- Age
- 5 years to 17 years
- People
- 60 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06869551 · EU 2024-517262-41-00